NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 1.7402
- -0.0198-1.13%
Close Feb 25 16:00 ET
- 1.8499
- +0.1097+6.30%
Post 20:01 ET
10.61MMarket Cap-0.67P/E (TTM)
1.8099High1.6800Low105.11KVolume1.7700Open1.7600Pre Close180.61KTurnover1.73%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High4.28P/B10.61MFloat Cap1.290052wk Low--Dividend TTM6.10MShs Float1419.0000Historical High--Div YieldTTM7.38%Amplitude1.2900Historical Low1.7180Avg Price1Lot Size
About Can-Fite BioPharma Company
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Company Profile
SymbolCANF
Company NameCan-Fite BioPharma
Listing DateSep 10, 2012
Founded1994
CEOMr. Motti Farbstein
MarketAMEX
Employees5
Securities TypeDR
ADS Ratio1.0 : 300.0
Fiscal Year Ends12-31
Address26 Ben Gurion Street
CityRamat Gan
CountryIsrael
Zip Code5257346
Phone972-3-924-1114
Websitehttp://www.canfite.com
Company Executives
- Name
- Position
- Salary
- Motti Farbstein
- Chief Executive Officer, Chief Operating and Financial Officer
- 467.00K
- Dr. Pnina Fishman, PhD
- Chief Scientific Officer and Executive Chairman of the Board
- 703.00K
- Dr. Sari Fishman, PhD
- Vice President, Business Development
- 373.00K
- Dr. Ilan Cohn, PhD
- Director
- --
- Dr. Abraham Sartani
- Director
- --
- Yoseph Bornstein
- Independent Director
- --
- Guy Regev
- Independent Director
- 60.00K
- Yaacov Goldman
- Independent Director
- 60.00K